NCT04557150
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04557150
Title A Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of RO7425781 in Participants With Relapsed or Refractory Multiple Myeloma (r/r MM)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: senior | adult
Covered Countries NZL | ITA | GBR | FRA | ESP | DNK | BEL | AUS

Facility Status City State Zip Country Details
Peter MacCallum Cancer Center Melbourne Victoria 3000 Australia Details
UZ Gent Ghent 9000 Belgium Details
Rigshospitalet København Ø 2100 Denmark Details
Odense Universitetshospital Odense C 5000 Denmark Details
CHRU Lille - Hôpital Claude Huriez Lille 59037 France Details
CHU NANTES - Hôtel Dieu Nantes 44093 France Details
Hopital De Haut Leveque Pessac 33604 France Details
IRCCS Istituto Nazionale dei Tumori di Napoli - Pascale Ematologia Oncologica Napoli Campania 80131 Italy Details
Policlinico S.Orsola-Malpighi Bologna Emilia-Romagna 40138 Italy Details
Fond. IRCCS Istituto Nazionale Tumori Milan Lombardy 20133 Italy Details
Instituto Clinico Humanitas Rozzano Lombardy 20089 Italy Details
New Zealand Clinical Research - Auckland Auckland 1010 New Zealand Details
Seoul National University Hospital Seoul 03080 South Korea Details
Samsung Medical Center Seoul 06351 South Korea Details
Seoul St Mary's Hospital Seoul 06591 South Korea Details
Hospital Universitario Marques de Valdecilla Santander Cantabria 39008 Spain Details
Clinica Universitaria de Navarra Pamplona Navarre 31008 Spain Details
Hospital Clinico Universitario de Salamanca Salamanca 37007 Spain Details
St James University Hospital Leeds LS9 7TF United Kingdom Details
University College London Hospitals NHS Foundation Trust London W1T 7HA United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field